210 related articles for article (PubMed ID: 21119261)
1. Crystalline maculopathy: a rare complication of tamoxifen therapy.
Srikantia N; Mukesh S; Krishnaswamy M
J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
[TBL] [Abstract][Full Text] [Related]
2. Branch retinal vein occlusion associated with tamoxifen use.
Onder Hİ; Kilic AC; Kose SA; Karatas A; Kaya E; Kaya M; Tunc M
Semin Ophthalmol; 2013 Mar; 28(2):88-90. PubMed ID: 23448563
[TBL] [Abstract][Full Text] [Related]
3. The eyes have it! Tamoxifen maculopathy revisited: a case report.
Nair AG; Das D; Goyal A; Gandhi RA
J Ocul Pharmacol Ther; 2012 Dec; 28(6):640-2. PubMed ID: 22731242
[TBL] [Abstract][Full Text] [Related]
4. Crystalline deposits in the macula - tamoxifen maculopathy or macular telangiectasia?
Rijal RK; Nakhwa C; Sindal MD
Nepal J Ophthalmol; 2014; 6(2):227-9. PubMed ID: 25680254
[TBL] [Abstract][Full Text] [Related]
5. To stop or not? Tamoxifen therapy for secondary prevention of breast cancer in a patient with ocular toxicity.
Bommireddy T; Carrim ZI
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759403
[TBL] [Abstract][Full Text] [Related]
6. Retinal changes associated with tamoxifen treatment for breast cancer.
Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
[TBL] [Abstract][Full Text] [Related]
7. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography findings in tamoxifen retinopathy.
Gualino V; Cohen SY; Delyfer MN; Sahel JA; Gaudric A
Am J Ophthalmol; 2005 Oct; 140(4):757-8. PubMed ID: 16226541
[TBL] [Abstract][Full Text] [Related]
9. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
10. [Atrophic tamoxifen maculopathy].
Hui-Bon-Hoa AA; Defoort-Dhellemmes S; Tran TH
J Fr Ophtalmol; 2011 Jan; 34(1):35.e1-5. PubMed ID: 21112124
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen maculopathy.
Alwitry A; Gardner I
Arch Ophthalmol; 2002 Oct; 120(10):1402. PubMed ID: 12365930
[No Abstract] [Full Text] [Related]
12. Tamoxifen maculopathy: The importance of screening and long follow-up.
Zamorano Martín F; Rocha-de-Lossada C; Rachwani Anil R; Borroni D; Rodriguez Calvo de Mora M; España Contreras M
J Fr Ophtalmol; 2020 Oct; 43(8):727-730. PubMed ID: 32620415
[TBL] [Abstract][Full Text] [Related]
13. Ocular toxicity of tamoxifen.
Gerner EW
Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
[TBL] [Abstract][Full Text] [Related]
14. [Unusual symptoms for tamoxifen-associated maculopathy].
Hager T; Hoffmann S; Seitz B
Ophthalmologe; 2010 Aug; 107(8):750-2. PubMed ID: 20393723
[TBL] [Abstract][Full Text] [Related]
15. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy.
Bourla DH; Sarraf D; Schwartz SD
Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen and ocular toxicity.
Ah-Song R; Sasco AJ
Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
[TBL] [Abstract][Full Text] [Related]
17. Ocular toxicity in low-dose tamoxifen: a prospective study.
Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
[TBL] [Abstract][Full Text] [Related]
18. A rare case: Branch retinal vein occlusion associated with the use of tamoxifen.
Demirci NS; Erdem GU; Uçgun Nİ; Bozkaya Y; Ozdemir NY; Dogan M; Zengin N
J Cancer Res Ther; 2019; 15(3):722-724. PubMed ID: 31169251
[TBL] [Abstract][Full Text] [Related]
19. Retinal changes associated with tamoxifen treatment for breast cancer.
Murray DC; Gibson JM
Eye (Lond); 1998; 12 ( Pt 3a)():485-6. PubMed ID: 9775258
[No Abstract] [Full Text] [Related]
20. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
